Web Analytics

3 Latest Announced Rounds

  • $50,000,000
    Unknown

    4 Investors

    Hospital & Health Care
    Jul 2nd, 2024
  • $1,600,000
    Unknown

    1 Investors

    Retail Apparel and Fashion
    Jul 2nd, 2024
  • $13,500,000
    Series A

    3 Investors

    Technology, Information and Internet
    Jul 2nd, 2024
$2,110.02M Raised in 92 Funding Rounds in the past 7 Days - View All

Funding Round Profile

AltPep

start up
United States - Seattle, Washington
  • 26/06/2023
  • Series B
  • $53,000,000

AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach.

Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.


Related People

Valerie DaggettFounder

Valerie Daggett United States - Seattle, Washington

N/A